shutterstock_1194559765_mariax
MariaX / Shutterstock.com
8 November 2019GeneticsSaman Javed

23andMe petitions Fed Circuit for en banc review

DNA testing and analysis company 23andMe has asked the full US Court of Appeals for the Federal Circuit to review an earlier panel decision which held that one of its patents is invalid.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
11 July 2019   The US Court of Appeals for the Federal Circuit yesterday, July 10, handed victory to researchers at the Chinese University of Hong Kong in a case involving a foetal testing patent.

More on this story

Americas
11 July 2019   The US Court of Appeals for the Federal Circuit yesterday, July 10, handed victory to researchers at the Chinese University of Hong Kong in a case involving a foetal testing patent.

More on this story

Americas
11 July 2019   The US Court of Appeals for the Federal Circuit yesterday, July 10, handed victory to researchers at the Chinese University of Hong Kong in a case involving a foetal testing patent.